Guest guest Posted June 2, 2008 Report Share Posted June 2, 2008 Dear Group, Last week I wrote Araid and asked for information on their new trial drug AP24534. I said I would let you know when and if I heard from them. Well I have had 2 emails from them already today and I am happy to report to your that you can also contact them if you want to find out if there is a trial near you. This is one of their email responses. " I can tell you that MDACC is one of two centers that are currently open and accepting patients. The trial is very early stage and is designed to assess appropriate dosing. The trials designed to fully explore efficacy will come later in the program. That said I would leave it to you and the physicians at MDACC to determine if you may be a candidate for the program. " If anyone is interested, write me and I will give you the name and email address to contact them. This is a highly touted trial and is also used in treating the dreaded mutation T315i. Blessings and peace, Lottie Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.